CORC  > 南华大学
AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.
Wang, Minglei; Li, Xuefeng; Zhang, Jin; Yang, Qiong; Chen, Wenqi; Jin, Weilin; Huang, Yi-Ran*; Yang, Ru*; Gao, Wei-Qiang*
刊名Theranostics
2017
卷号7期号:5页码:1100-1113
关键词*AHNAK2 *clear cell Renal Cell Carcinoma *epithelial-mesenchymal transition. *hypoxia pathway *hypoxia-inducible factor-1alpha
ISSN号1838-7640
DOI10.7150/thno.18198
URL标识查看原文
WOS记录号WOS:000396574200005
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5675628
专题南华大学
作者单位1.[Wang, Minglei
2.Li, Xuefeng
3.Yang, Qiong
4.Chen, Wenqi
5.Yang, Ru
6.Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Renji MedX Stem Cell Res Ctr,Ren Ji Hosp, Shanghai 200127, Peoples R China.
推荐引用方式
GB/T 7714
Wang, Minglei,Li, Xuefeng,Zhang, Jin,et al. AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.[J]. Theranostics,2017,7(5):1100-1113.
APA Wang, Minglei.,Li, Xuefeng.,Zhang, Jin.,Yang, Qiong.,Chen, Wenqi.,...&Gao, Wei-Qiang*.(2017).AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma..Theranostics,7(5),1100-1113.
MLA Wang, Minglei,et al."AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.".Theranostics 7.5(2017):1100-1113.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace